This is the authors' abstract. We don't add key points for this paper.
We report here the electrogenerated chemiluminescence (ECL) of a red fluorophore diphenylaminospirobifluorenylfumaronitrile (FPhSPFN). FPhSPFN contains two diphenylamino groups as strong electron donors at the ends linked through a nonplanar bulky spirobifluorene linker to a common fumaronitrile group as a strong electron acceptor. The cyclic voltammetry of this compound shows two one-electron transfer reduction waves and one single overall two-electron oxidation wave consisting of closely spaced waves with a peak separation of 63 mV. Chronoamperometry with an ultramicroelectrode (UME) confirmed that each reduction wave involves a 1e transfer and that the oxidation wave contains an overall 2e transfer. The first reduction wave is Nernstian, E o 1,red = −1.09 V versus SCE, and the second reduction wave, E o 2,red = −1.50 V versus SCE, produces a film on the electrode. By comparison to a digital simulation, the oxidation is assigned to two reversible, closely spaced, one-electron processes for oxidation with E o 1,ox = 1.05 V and E o 2,ox = 1.11 V versus SCE. A large wavelength shift (∼35 nm) was observed in ECL as compared to photoluminescence (PL). The ECL spectrum showed a maximum emission at 708 nm with a red-shifted shoulder at around 750 nm. ECL was studied in mixtures of benzene/acetonitrile at different composition ratios; an increase in the ratio of the ECL intensity of the shoulder with respect to the main peak emission was observed with increasing solvent polarity. ECL generated with BPO as a coreactant also showed the red-shifted shoulder at the same ratio as that with annihilation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: